SUZANNA FARMER: Open Payments
NPI 1699806851 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 54 payments from 13 companies in 2025. Trend: 2023 $1,050 · 2024 $1,407 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 14 | $336 |
| Gilead Sciences, Inc. | 13 | $280 |
| ABBVIE INC. | 8 | $136 |
| Merck Sharp & Dohme LLC | 6 | $124 |
| Paratek Pharmaceuticals, Inc. | 3 | $63 |
| Napo Pharmaceuticals Inc | 2 | $45 |
| Insmed, Inc. | 2 | $40 |
| Ferring Pharmaceuticals Inc. | 1 | $35 |
| CSL Behring | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
Products named: CABENUVA, DOVATO, PIFELTRO, DALVANCE, NUZYRA, Mytesi, Arikayce, REBYOTA.
Industry payments across TX — which companies pay providers there.
